- Home
- XERS vs MLKN Comparison
XERS vs MLKN Comparison
Compare XERS & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | MLKN |
|---|---|---|
| Founded | 2005 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | XERS | MLKN |
|---|---|---|
| Price | $7.28 | $19.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $10.43 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 507.1K |
| Earning Date | 03-02-2026 | 12-17-2025 |
| Dividend Yield | N/A | ★ 3.91% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $266,137,000.00 | ★ $3,748,900,000.00 |
| Revenue This Year | $44.77 | $6.57 |
| Revenue Next Year | $27.72 | $4.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.05 | 4.34 |
| 52 Week Low | $3.38 | $13.77 |
| 52 Week High | $10.08 | $23.47 |
Technical Indicators
Market Signals| Indicator | XERS | MLKN |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 58.24 |
| Support Level | $7.36 | $18.99 |
| Resistance Level | $7.65 | $19.75 |
| Average True Range (ATR) | 0.30 | 0.60 |
| MACD | -0.04 | -0.10 |
| Stochastic Oscillator | 18.37 | 58.19 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.